What is the treatment for Methicillin-resistant Staphylococcus aureus (MRSA) skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of MRSA Skin Infections

For MRSA skin infections, first-line treatment includes oral antibiotics such as trimethoprim-sulfamethoxazole (TMP-SMX), doxycycline, or clindamycin, along with incision and drainage of any abscesses. 1

First-Line Treatment Options

Outpatient Management

  • Incision and drainage is essential for purulent lesions
  • Oral antibiotic options:
    • Trimethoprim-sulfamethoxazole (TMP-SMX): 1-2 double-strength tablets (160mg/800mg) twice daily
    • Doxycycline: 100 mg twice daily (not recommended for children under 8 years)
    • Clindamycin: 300-450 mg three times daily (effective against both MRSA and streptococci)
    • For pediatric patients ≤45 kg: doxycycline 2 mg/kg/dose every 12 hours 1

Treatment Duration

  • Uncomplicated skin infections: 5-10 days
  • Complicated skin infections: 7-14 days 1

Alternative Treatment Options

For Treatment Failures or Severe Infections

  • Linezolid: 600 mg orally twice daily 1, 2

    • FDA-approved for acute bacterial skin and skin structure infections (ABSSSI) caused by MRSA
    • Particularly effective for treatment failures
    • Clinical cure rates of 79% for MRSA skin infections 2
  • Tedizolid: 200 mg once daily for 6 days 3

    • FDA-approved for ABSSSI caused by MRSA in patients 12 years and older
    • Can be administered orally or intravenously
    • Shorter treatment duration (6 days) compared to other options

For Hospitalized Patients

  • Vancomycin: 15-20 mg/kg/dose every 8-12 hours IV

    • Loading dose of 25-30 mg/kg for serious infections
    • Target trough concentrations of 15-20 μg/mL 1
  • Daptomycin: Dosage determined by healthcare professional

    • Particularly useful for MRSA bacteremia with skin manifestations 1

Supportive Care Measures

  • Elevation of affected limb to promote drainage of edema
  • Proper wound care, including cleansing and debridement of necrotic tissue
  • Regular assessment of clinical response within 48-72 hours 1

Management Algorithm

  1. Assess severity:

    • Localized infection vs. systemic symptoms
    • Presence of abscess vs. cellulitis
    • Patient risk factors (immunocompromised, etc.)
  2. For localized abscess:

    • Perform incision and drainage
    • Consider antibiotic therapy based on size, location, and patient factors
  3. For cellulitis or post-drainage therapy:

    • Start empiric oral antibiotic (TMP-SMX, doxycycline, or clindamycin)
    • Reassess in 48-72 hours
  4. If no improvement:

    • Reassess diagnosis
    • Check culture results if available
    • Consider alternative antibiotic (linezolid or tedizolid)
    • Evaluate for hospitalization if worsening
  5. For severe infections:

    • Hospitalize for IV antibiotics (vancomycin or daptomycin)
    • Consider surgical consultation

Prevention of Recurrence and Spread

  • Cover draining wounds with clean, dry bandages
  • Regular hand hygiene with soap and water or alcohol-based hand gel
  • Avoid sharing personal items that contact skin
  • Consider decolonization for recurrent infections:
    • Nasal mupirocin twice daily for 5-10 days
    • Chlorhexidine body washes for 5-14 days or dilute bleach baths 1

Common Pitfalls to Avoid

  • Failure to drain abscesses: Antibiotics alone are often insufficient for purulent collections
  • Inadequate follow-up: Assess clinical response within 48-72 hours
  • Inappropriate antibiotic selection: Consider local resistance patterns
  • Insufficient treatment duration: Complete the full course of antibiotics
  • Neglecting decolonization: Consider for recurrent infections
  • Overlooking household contacts: Evaluate close contacts for evidence of infection to prevent spread 1

References

Guideline

Treatment of MRSA Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.